Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$6.33B
+168.3% from 2023
Prescriptions
5.1M
$1,241.24 per claim
Patients
894K
194,653 prescribers
Total spending, 2024
$6.34B
$7,083.70 per patient
Medicare prescription drug plans paid $6.33B for Mounjaro in 2024, for 5,103,556 prescriptions and refills to 894,243 patients (up 168.3% from 2023). The average cost per claim was $1,241.24.
Texas had the highest Medicare cost for Mounjaro in 2024: $624.0M for 491,789 claims, followed by Florida ($494.1M).
Shahed Quyyumi, endocrinology in Staten Island, NY, had the highest Medicare cost for Mounjaro in 2024: 1,709 claims costing $2.5M.
Mounjaro is made by Eli Lilly and Company (LLY), listed in the Medicare spending data as Eli Lilly & Co..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Shahed Quyyumi Staten Island, NY | Endocrinology | 1,709 | 299 | $2.5M |
| Eugenio Angueira-Serrano Miami, FL | Endocrinology | 1,949 | 293 | $2.1M |
| Stella Ilyayeva |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 30,007 | 121,050 | 54,187 | $144.0M |
| 2023 | 118,860 | 1,820,883 | 370,074 | $2.36B |
| 2024 | 194,653 | 5,103,556 | 894,243 | $6.33B |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 1,720 |
| 316 |
| $2.0M |
| Chitharanjan Duvoor Jonesboro, AR | Endocrinology | 1,348 | 250 | $1.9M |
| Iraklii Buziashvili Brooklyn, NY | Endocrinology | 1,704 | 305 | $1.8M |
| Gary Reznik Los Angeles, CA | Cardiology | 1,751 | 214 | $1.8M |
| Anastasios Manessis New York, NY | Endocrinology | 1,281 | 256 | $1.7M |
| Muhammad I Choudhry Weatherford, TX | Endocrinology | 1,146 | 249 | $1.6M |
| Najmuddin K Karimjee Houston, TX | Internal Medicine | 1,199 | 271 | $1.6M |
| Matthew F Kamil Concord, NH | Endocrinology | 1,096 | 202 | $1.6M |
| Swarna Varma Pittsburgh, PA | Endocrinology | 1,268 | 189 | $1.5M |
| Mohammad T Ijaz Zanesville, OH | Endocrinology | 1,363 | 222 | $1.5M |
| Vita Anksh Naples, FL | Endocrinology | 1,206 | 203 | $1.5M |
| Kalyani Regeti North Port, FL | Endocrinology | 892 | 170 | $1.4M |
| Joseph Terrana Nesconset, NY | Endocrinology | 1,043 | 170 | $1.4M |
| Wael E Eid Covington, KY | Endocrinology | 1,084 | 212 | $1.4M |
| Amer Issa Saginaw, MI | Endocrinology | 1,089 | 219 | $1.4M |
| Matin Sharafatkhah Brooklyn, NY | Endocrinology | 1,331 | 196 | $1.4M |
| Benjamin D Prohaska Reno, NV | Physician Assistant | 960 | 169 | $1.4M |
| Rory S Breidbart New Hyde Park, NY | Endocrinology | 1,017 | 143 | $1.4M |
| Pamela Lopez Weslaco, TX | Nurse Practitioner | 881 | 193 | $1.4M |
| Carla L Hudson Opelika, AL | Nurse Practitioner | 1,141 | 192 | $1.3M |
| Monica G Robles Anniston, AL | Endocrinology | 850 | 188 | $1.3M |
| Robert M Oberstein Hartford, CT | Endocrinology | 986 | 148 | $1.3M |
| Leila Chaychi San Carlos, CA | Endocrinology | 957 | 167 | $1.3M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Eli Lilly & Co. LLY | 5,105,397 | $6.34B |